Department of Medicine Hematology/Oncology |
Hematology/Oncology |
Lung cancer treatment |
Boston: Massachusetts General Hospital |
MD,Harvard Medical School PhD,Harvard University |
Medical Oncology, American Board of Internal Medicine |
Female |
Adult |
Yes |
View list » Aetna Health Inc. Beech Street Blue Cross Blue Shield - Blue Care 65 Blue Cross Blue Shield - Indemnity Blue Cross Blue Shield - Managed Care Blue Cross Blue Shield - Partners Plus BMC HealthNet Mass Health MCO/ACO Cigna (PAL #'s) Commonwealth Care Alliance Fallon Community HealthCare Great-West Healthcare (formally One Health Plan) Harvard Pilgrim Health Plan - ACD Harvard Pilgrim Health Plan - PBO Health Care Value Management (HCVM) Humana/Choice Care PPO MassHealth Medicare Medicare - ACD Neighborhood Health Plan - ACD Neighborhood Health Plan - PBO OSW - Maine OSW - New Hampshire OSW - Rhode Island Private Health Care Systems (PHCS) Senior Whole Health TriCare Tufts Health Plan Unicare United Healthcare (non-HMO) - ACD United Healthcare (non-HMO) - PBO Well Sense Pediatrics « Hide list |
Alice T. Shaw, MD, PhD, is an attending physician in the Center for Thoracic Cancers at Massachusetts General Hospital and an associate professor of medicine at Harvard Medical School. 
In addition to caring for patients with lung cancer, Dr. Shaw also performs clinical and translational research.
Dr. Shaw's major research interests include studying anaplastic lymphoma kinase (ALK) and ROS1 rearrangements in non-small cell lung carcinoma (NSCLC). 
She is also studying how lung cancers develop resistance to targeted therapies, and this work has led to a number of novel treatment strategies to overcome resistance in the clinic. 
Dr Shaw has been awarded a number of research grants, including grants from the Damon Runyon Cancer Research Foundation, the Burroughs Welcome Fund, the V Foundation for Cancer Research, Uniting Against Lung Cancer, the National Foundation for Cancer Research, and the NIH/NCI.